Gene · 246100
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets. | Discov Oncol | 2025 | 39864021 | PubTator, text mining | PubMed |
| Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma. | J Clin Oncol | 2025 | 39836945 | PubTator, text mining | PubMed |
| De novo design and structure of a peptide-centric TCR mimic binding module. | bioRxiv | 2025 | 39763827 | PubTator, text mining | PubMed |
| GTO: a comprehensive gene therapy omnibus. | Nucleic Acids Res | 2025 | 39540438 | PubTator, text mining | PubMed |
| Immunoinformatic approach to design an efficient multi-epitope peptide vaccine against melanoma. | Biotechnol Appl Biochem | 2025 | 39245893 | PubTator, text mining | PubMed |
| Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study. | BJU Int | 2025 | 39101639 | PubTator, text mining | PubMed |
| Immune-reactive tumor organoids system to determine the effects of microbial metabolites on cancer immunity and immunotherapies. | Front Microbiomes | 2024 | 41742931 | PubTator, text mining | PubMed |
| Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system. | Front Immunol | 2024 | 39776913 | PubTator, text mining | PubMed |
| Screening and regulatory mechanism exploration of M1 macrophage polarization and efferocytosis-related biomarkers in coronary heart disease. | Front Cardiovasc Med | 2024 | 39723414 | PubTator, text mining | PubMed |
| De novo functional discovery of peptide-MHC restricted CARs from recombinase-constructed large-diversity monoclonal T cell libraries. | bioRxiv | 2024 | 39651191 | PubTator, text mining | PubMed |
| Novel pharmacotherapies for the treatment of liposarcoma: a comprehensive update. | Expert Opin Pharmacother | 2024 | 39535168 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in Therapy. | Cells | 2024 | 39451213 | PubTator, text mining | PubMed |
| An immunoinformatics approach for a potential NY-ESO-1 and WT1 based multi-epitope vaccine designing against triple-negative breast cancer. | Heliyon | 2024 | 39286192 | PubTator, text mining | PubMed |
| NY-ESO-1 antigen: A promising frontier in cancer immunotherapy. | Clin Transl Med | 2024 | 39275923 | PubTator, text mining | PubMed |
| Different estimation techniques and data analysis for constant-partially accelerated life tests for power half-logistic distribution. | Sci Rep | 2024 | 39242750 | PubTator, text mining | PubMed |
| Engineered NKG2C + NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome. | bioRxiv | 2024 | 39211122 | PubTator, text mining | PubMed |
| Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma. | Med Oncol | 2024 | 39143271 | PubTator, text mining | PubMed |
| Amplifiable protein identification via residue-resolved barcoding and composition code counting. | Natl Sci Rev | 2024 | 39055168 | PubTator, text mining | PubMed |
| Potentially actionable targets in synovial sarcoma: A tissue microarray study. | Transl Oncol | 2024 | 39029378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/246100/papers?page=7